3D Tissue Models
Targeting Diabetes With Novel Therapeutics
World Trade Center
200 Seaport Boulevard
Boston, MA

Schedule of Presentations:

Wednesday, October 22, 2008
07:00:00 Registration Open
12:00:00 New Presentation
14:00:00 Chairperson’s Remarks Jesper Gromada
14:10:00 FGF-21 for the Treatment of Type 2 Diabetes Jesper Gromada
14:40:00 11beta-HSD1 Inhibition as an Entrée to Cardio-Metabolic Benefit in Type 2 Diabetes Reid Huber
15:10:00 Antidiabetic Effects of Glucokinase Activators: From Benchside to Bedside Joseph Grimsby
15:40:00 Networking Refreshment Break in the Exhibit Hall
16:20:00 Discovery of a Second Generation FBPase Inhibitor, MB07803, with Reduced Metabolism, Improved Oral Bioavailability, and Clinical POC in Type 2 Diabetic Patients Max Dang
16:50:00 Technology Watch (Sponsorship Available)
17:20:00 SGLT2 Inhibition: A Novel Approach to the Treatment of Type 2 Diabetes Jean Whaley
17:50:00 Managing Diabetes with an Amylin Mimetic: A Step Closer to Restoring Normal Physiology Elaine Chiquette
18:20:00 End of Day
Thursday, October 23, 2008
07:30:00 Morning Coffee
08:35:00 Chairperson’s Remarks Peter J. Oates
08:40:00 A Systems Biology Approach to Dissecting the Topology of the Insulin Signaling Network Norbert Perrimon
09:10:00 Chemical Screening for Modulators of Beta Cell Differentiation and Proliferation Julia Lamenzo
09:40:00 Modeling Complex Mechanisms of Action in Diabetes Therapy Richard Ho
10:10:00 Networking Coffee Break in the Exhibit Hall
10:55:00 Diabetic Complications and the Polyol Pathway: Lessons Learned and a New Paradigm Peter J. Oates
11:25:00 GPR40 Agonists for the Treatment of Type 2 Diabetes Daniel Lin
11:55:00 GPR119 Agonists Mediate Glycemic Control via a Glucose Dependent Insulinotropic and Incretinotropic Action
12:00:00 New Presentation
12:25:00 Luncheon Technology Workshop (Sponsorship Available) or Lunch on Your Own
12:55:00 Session Break
13:55:00 Chairperson’s Remarks Richard E Pratley
14:00:00 Incretins Michael Hanley
14:30:00 Incretin Mimetics: Clinical Perspective and Position in the T2DM Treatment Algorithm Richard E Pratley
15:00:00 Networking Ice Cream Refreshment Break in the Exhibit Hall (Last Chance for Viewing)
15:40:00 GLP-1: Physiology and Therapeutic Potential Rachele Berria
16:10:00 The Future of Incretins as a Target for Diabetes PANEL DISCUSSION Richard E Pratley
17:10:00 Close of Targeting Diabetes with Novel Therapeutics Conference
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.